Found 8 matching trials
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+) PHASE1 Iadademstat is being studied as a treatment for subjects with Relapsed or R...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer PHASE1 This phase I/II trial tests the safety, side effects, and best dose of iada...
Show More Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML PHASE1 This phase I trial tests safety, side effects and best dose of iadademstat ...
Show More Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Learn More & Join Trial
Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome PHASE1 This is a phase I study with a primary objective of determining the recomme...
Show More Location
Froedtert Hospital & the Medical College of Wisconsin
Learn More & Join Trial
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) PHASE2 This phase II trial compares the effect of ASTX727 in combination with iada...
Show More Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Learn More & Join Trial
Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET PHASE2 This is a non-randomized single-arm, two cohorts, phase II study of iadadem...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia PHASE1 This phase I trial tests the safety, side effects, and best dose of iadadem...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Iadademstat + SBRT With Atezo in ES-SCLC PHASE1 This is a phase 1b dose escalation, open-label, non-randomized study of par...
Show More Learn More & Join Trial